Abstract
Telomerase is a ribonucleoprotein complex mainly composed of a reverse transcriptase catalytic subunit (telomerase reverse transcriptase gene, hTERT) that copies a template region of its RNA subunit to the end of the telomere. For detecting telomerase activity in a tissue specimen the TRAP assay is a relatively sensitive and specific method, but it can be used only on fresh tissue extracts and offers no information at the single cell level. Immunohistochemistry (IHC) allows to detect hTERT protein expression at an individual cell level in human tissues. We have tested commercially available anti-hTERT antibodies in formalin-fixed and paraffin-embedded human tissues by IHC. Only one monoclonal antibody (NCL-hTERT; Novacastra) was sufficiently specific and this was applied to human tissues in which telomerase activity had been shown by TRAP assay and hTERT mRNA expression by RT-PCR. hTERT protein localized diffusely in the nucleoplasm and more intensely in the nucleoli of cancer cells and proliferating normal cells. Mitotic cells showed diffuse staining of the entire cell. Granular cytoplasmic staining was occasionally found in some tumor cells. In telomerase-positive tumors not all the tumor cells showed hTERT immunoreactivity. A significantly heterogeneous hTERT protein expression was observed in human tumor tissues. The hTERT immunostaining in fixed tissues was concordant with telomerase activity and hTERT mRNA expression in corresponding non-fixed samples. Quantitative RT-PCR of microdissected sections showed that hTERT mRNA expression was higher in cells with nuclear expression than in those with cytoplasmic expression. Double staining with the M30 antibody showed that a subpopulation of hTERT-negative cells is apoptotic. We conclude that: (1) hTERT protein can be detected by IHC in fixed human tissues, but the choice of the antibody, tissue processing, and reaction conditions are critical, (2) hTERT protein localizes in the nucleoplasm, more strongly in the nucleolus, and occasionally in the cytoplasm, (3) telomerase-positive tumors show significant heterogeneity of hTERT protein expression, and (4) a subpopulation of hTERT protein negative tumor cells is identified as apoptotic cells.
Similar content being viewed by others
References
Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, MItsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC (2003) Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 63:18–21
Broccoli D, Young JW, de Lange T (1995) Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 92:9082–9086
Dhaene K, Wauters J, Weyn B, Timmermans JP, Van Marck E (2000) Expression profile of telomerase subunits in human pleural mesothelioma. J Pathol 190:80–85
Effros RB, Globerson A (2002) Hematopoietic cells and replicative senescence. Exp Gerontol 37:191–196
Guilleret I, Yan P, Grange F, Braunschweig R, Bosman FT, Benhattar J (2002) Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Cancer 101:335–341
Guillou L, Coindre J, Gallagher G, Terrier P, Gebhard S, Saint Aubain SN, Michels J, Jundt G, Vince DR, Collin F, Trassard M, Le DV, Benhattar J (2001) Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives. Hum Pathol 32:105–112
Hiyama E, Hiyama K (2002) Clinical utility of telomerase in cancer. Oncogene 21:643–649
Hiyama E, Hiyama K, Yokoyama T, Shay JW (2001) Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 3:17–26
Kyo S, Masutomi K, Maida Y, Kanaya T, Yatabe N, Nakamura M, Tanaka M, Takarada M, Sugawara I, Murakami S, Taira T, Inoue M (2003) Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase. Am J Pathol 163:859–867
Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33:787–791
Tahara H, Yasui W, Tahara E, Fujimoto J, Ito K, Tamai K, Nakayama J, Ishikawa F, Tahara E, Ide T (1999) Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 18:1561–1567
Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR (2001) Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 91:644–649
Wei R, Younes M (2002) Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign colonic mucosa. Hum Pathol 33:693–696
Wong JM, Kusdra L, Collins K (2002) Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 4:731–736
Yi X, Shay JW, Wright WE (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 29:4818–4825
Acknowledgements
The authors thank B. Jaspers for helpful discussions. This work was supported by a contract with Aventis Pharma Recherche-Developpement, France and by the Swiss National Science Foundation (grant number: 3100AO-101732).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yan, P., Benhattar, J., Seelentag, W. et al. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 121, 391–397 (2004). https://doi.org/10.1007/s00418-004-0645-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-004-0645-5